By Deena Beasley San Francisco (Reuters) – Drugmakers are prioritizing complex biotech medicines over treatments that can be given as…
Nepal inflation eases to 7.38% as food, beverage prices dip
By Gopal Sharma KATHMANDU (Reuters) – Nepal’s inflation eased to 7.38% in the month to mid-December, the lowest in about…
Mark Cuban’s pharmaceuticals startup ties up with RxPreferred (Jan. 11)
(This Jan. 11 story has been corrected to remove reference to EmsanaRx as part of a nonprofit coalition in the…
China outbound flight bookings at 15% of pre-pandemic levels despite recent surge – ForwardKeys
By Jamie Freed (Reuters) -China’s outbound flight bookings were at only 15% of pre-pandemic levels in the week after the…
U.S. to announce list of drugs for pricing negotiations Sept. 1
By Ahmed Aboulenein WASHINGTON (Reuters) – The U.S. government will announce a list of 10 prescription drugs for which it…
Environment risks dominate in “polycrisis” world – WEF survey
By Mark John (Reuters) – Failure to tackle climate change and environmental degradation dominate the ranking of top risks facing…
Sen. Sanders asks Moderna not to hike COVID vaccine price
By Michael Erman (Reuters) -U.S. Senator Bernie Sanders sent Moderna Inc a letter this week asking the drug company to…
Abbvie raises sales outlook of two immunology drugs to more than $17.5 billion in 2025
(Reuters) -AbbVie Inc on Tuesday raised its 2025 sales forecast of its newer immunology drugs Skyrizi and Rinvoq to more…
GE HealthCare expects organic revenue growth of 5%-7% in 2023
(Reuters) – GE HealthCare Technologies Inc expects 2023 organic revenue growth to be in the range of 5% to 7%,…
Asian tourism-focused businesses ready for China rebound as border reopens
By Minwoo Park, Chris Gallagher and Jiraporn Kuhakan SEOUL/TOKYO/BANGKOK (Reuters) – South Korean and Japanese shop owners, Thai tour bus…